These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lipoprotein Lp(a) and atherothrombotic disease. de la Peña-Díaz A; Izaguirre-Avila R; Anglés-Cano E Arch Med Res; 2000; 31(4):353-9. PubMed ID: 11068075 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits. Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) in health and disease. Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507 [TBL] [Abstract][Full Text] [Related]
7. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1). Dieplinger H; Kronenberg F Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265 [TBL] [Abstract][Full Text] [Related]
8. Structure and possible biological roles of Lp(a). Karmansky I; Gruener N Clin Biochem; 1994 Jun; 27(3):151-62. PubMed ID: 7923754 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) in renal disease. Kronenberg F; Utermann G; Dieplinger H Am J Kidney Dis; 1996 Jan; 27(1):1-25. PubMed ID: 8546123 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. Kojima S; Harpel PC; Rifkin DB J Cell Biol; 1991 Jun; 113(6):1439-45. PubMed ID: 1828468 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of fibrinolysis by lipoprotein(a). Anglés-Cano E; de la Peña Díaz A; Loyau S Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483 [TBL] [Abstract][Full Text] [Related]
12. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease. Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191 [TBL] [Abstract][Full Text] [Related]
14. The role of lipoprotein(a) in atherogenesis and thrombosis. Hajjar KA; Nachman RL Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793 [TBL] [Abstract][Full Text] [Related]
15. [Lipoprotein(a): a link between thrombosis and atherosclerosis?]. Hansen PR Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983 [TBL] [Abstract][Full Text] [Related]
16. [Research progress in lipoprotein (a): aspects of biochemistry and molecular biology]. Huang YT Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):25-30. PubMed ID: 8731979 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation. Sato Y; Kobori S; Sakai M; Yano T; Higashi T; Matsumura T; Morikawa W; Terano T; Miyazaki A; Horiuchi S; Shichiri M Atherosclerosis; 1996 Aug; 125(1):15-26. PubMed ID: 8831923 [TBL] [Abstract][Full Text] [Related]
19. Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation. Kronenberg F; Trenkwalder E; Lingenhel A; Friedrich G; Lhotta K; Schober M; Moes N; König P; Utermann G; Dieplinger H J Lipid Res; 1997 Sep; 38(9):1755-63. PubMed ID: 9323585 [TBL] [Abstract][Full Text] [Related]